With its significant cash infusions from offloading its COVID assets, Novavax had just over $1 billion as it exited Q3, 2024.

Danaher faced a disappointing 2024, despite beating Q3 expectations, due to unaltered full-year guidance and a significant ...

In a challenging market marked by uncertainty, building a resilient portfolio is key to long-term financial stability. Read ...

I discuss adding to an income-focused CEF portfolio monthly, opportunities in volatile market, and holding cash for potential ...

Concentrated portfolios need periodic rebalancing to avoid value traps. Read about these stock selections to help keep ...

Partners Group Holding AG's performance fees may not double as anticipated in 2025 due to stagnant sponsor activity and ...

Neutral stance due to macro challenges, affordability concerns, and rising costs make it too risky to invest. Explore more ...

MGM Resorts International has a diverse portfolio of assets and promising growth opportunities. See why I think MGM stock is ...

American States Water's financial health is robust, boasting an A credit rating, and a low debt-to-capital ratio. Read why I ...

In the fourth quarter of 2024, equity markets were positive and large cap stocks generally outperformed small cap stocks.

DraftKings' growth is strong, but there's no clear path to profitability. Find out why I reiterate my sell rating for DKNG ...

The US dollar reached a new high in the Nominal US$ versus Advanced and Emerging series incepted in 2006. Read more ...